First and only EGFR inhibitor and targeted treatment approved in the EU in unresectable NSCLC . Approval based on LAURA Phase III trial results which showed Tagrisso extended medi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback